HCm guidelines icon

Hypertrophic Cardiomyopathy (Clinical Expert Consensus Document on)

ESC Clinical Practice Guidelines

Topics:

Myocardial Disease

Current versions available to download

Publication dateVersionsReferencesSize
2003Full TextEHJ 2003;24:1965-1991432 KB
 Pocket guidelines
 Slideset3 MB
 Related MaterialsBibliography157 KB

Authors

B. J. Maron and W. J. McKenna (Chairpersons), G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, E. D. Wigle

Endorsed by:

Table of contents: Full Text (ESC Clinical Practice Guidelines)

Introduction:
Organization of committee and evidence review, Purpose of this Expert Consensus Document

General considerations and perspectives

Nomenclature, definitions, and clinical diagnosis

Obstruction to LV Outflow

Genetics and molecular diagnosis
General considerations for natural history, and clinical course
Symptoms and pharmacological management strategies:
Beta-adrenergic blocking agents, Verapamil, Disopyramide, Drugs in end-stage phase, Asymptomatic patients, Infective endocarditis prophylaxis, Pregnancy

Treatment options for drug-refractory patients

Additional approaches to relieve outflow obstruction and symptoms:
Dual-chamber pacing, Percutaneous alcohol septal ablation

Sudden Cardiac Death:
Risk stratification, Prevention, Athlete recommendations

Atrial Fibrillation

Previous versions

A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here